Clinical Trials Browser

Phase 2 × NIH × FANG vaccine × Clear all

NCT00019097 2024-03-04

Vaccine Therapy in Treating Patients With Multiple Myeloma

Phase 2 Completed

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Neoplasms, Hematologic Neoplasms, Genetic Diseases, Inborn, Neoplasms, Plasma Cell

NCT00436930 2014-01-10

Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma

Phase 2 Completed

Melanoma

NCT00093522 2013-12-19

Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00003185 2013-12-04

Biological Therapy in Treating Patients With Glioblastoma Multiforme

Phase 2 Completed

Astrocytoma, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00002475 2013-07-10

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Phase 2 Completed

BreastGastrointestinalGenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT00002454 2011-07-26

Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx

Phase 2 Unknown

Precancerous Conditions